Back to search
FDAFDA · Food and drugs·Recall number D-0461-2020

Altaire Diclofenac Sodium Opthalmic Solution, 0.1%, 5 mL, Rx only, Manufactured Altaire Pharmaceuticals, NDC 59390-149-05

Published November 27, 2019 · Recall initiated: July 2, 2019

Summary

FDA records drug Class II recall D-0461-2020, published November 27, 2019 and initiated July 2, 2019. Recalling firm: Altaire Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 49527 units; Lot: 17225 07/19 17247 08/19 18038 02/20 18162 06/20 19014 01/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if DICLOFENAC has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DICLOFENAC
Manufacturer
Altaire Pharmaceuticals, Inc.
Distributor
U.S.A. Nationwide
Lot
17225 07/19 17247 08/19 18038 02/20 18162 06/20 19014 01/21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Altaire Diclofenac Sodium Opthalmic Solution, 0.1%, 5 mL, Rx only, Manufactured Altaire Pharmaceuticals, NDC 59390-149-05 recalled?

Yes. FDA published recall D-0461-2020 on November 27, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DICLOFENAC.